Lexicon Pharmaceuticals Inc (LXRX)
1.74
+0.04
(+2.35%)
USD |
NASDAQ |
May 03, 16:00
1.76
+0.02
(+1.15%)
After-Hours: 20:00
Lexicon Pharmaceuticals Accounts Payable (Quarterly): 8.067M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 8.067M |
December 31, 2023 | 14.39M |
September 30, 2023 | 12.04M |
June 30, 2023 | 10.50M |
March 31, 2023 | 10.31M |
December 31, 2022 | 10.40M |
September 30, 2022 | 9.427M |
June 30, 2022 | 7.347M |
March 31, 2022 | 9.321M |
December 31, 2021 | 9.152M |
September 30, 2021 | 8.345M |
June 30, 2021 | 8.545M |
March 31, 2021 | 4.926M |
December 31, 2020 | 5.469M |
September 30, 2020 | 11.73M |
June 30, 2020 | 29.76M |
March 31, 2020 | 18.24M |
December 31, 2019 | 12.18M |
September 30, 2019 | 20.91M |
June 30, 2019 | 10.03M |
March 31, 2019 | 13.87M |
December 31, 2018 | 12.05M |
September 30, 2018 | 51.48M |
June 30, 2018 | 50.45M |
March 31, 2018 | 66.55M |
Date | Value |
---|---|
December 31, 2017 | 38.76M |
September 30, 2017 | 52.63M |
June 30, 2017 | 43.86M |
March 31, 2017 | 41.94M |
December 31, 2016 | 52.88M |
September 30, 2016 | 41.54M |
June 30, 2016 | 28.22M |
March 31, 2016 | 25.54M |
December 31, 2015 | 19.72M |
September 30, 2015 | 16.36M |
June 30, 2015 | 11.29M |
March 31, 2015 | 12.14M |
December 31, 2014 | 13.06M |
September 30, 2014 | 9.741M |
June 30, 2014 | 8.35M |
March 31, 2014 | 7.072M |
December 31, 2013 | 9.715M |
September 30, 2013 | 9.709M |
June 30, 2013 | 6.281M |
March 31, 2013 | 5.442M |
December 31, 2012 | 7.661M |
September 30, 2012 | 4.306M |
June 30, 2012 | 4.579M |
March 31, 2012 | 5.324M |
December 31, 2011 | 6.042M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
4.926M
Minimum
Mar 2021
29.76M
Maximum
Jun 2020
11.55M
Average
10.17M
Median
Accounts Payable (Quarterly) Benchmarks
Windtree Therapeutics Inc | 0.809M |
AIM ImmunoTech Inc | 6.443M |
Perspective Therapeutics Inc | 6.107M |
Protalix BioTherapeutics Inc | 4.32M |
Armata Pharmaceuticals Inc | 1.585M |